QQ客服 官方微博 反馈留言

浏览/检索结果: 共13条，第1-10条 帮助 限定条件 专题：山东大学    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序提交时间升序提交时间降序题名升序题名降序作者升序作者降序 Therapeutic Effect Of First-Line EGFR-TKIs Combined With Concurrent Cranial Radiotherapy On NSCLC Patients With EGFR Activating Mutation And Brain Metastasis: A Retrospective Study 期刊论文 ONCOTARGETS AND THERAPY, 2019, 卷号: 12, 页码: 8311-8318 作者:  An, Ning;  Wang, Haoyi;  Li, Ji;  Zhai, Xiaoyang;  Jing, Wang 收藏  |  浏览/下载：36/0  |  提交时间：2019/12/11 non-small cell lung cancer  EGFR mutation  brain metastasis  radiotherapy  tyrosine kinase inhibitor   The clinical characteristic and prognostic factors of leptomeningeal metastasis in patients with non-small-cell lung cancer-a retrospective study from one single cancer institute 期刊论文 CANCER MEDICINE, 2019, 卷号: 8, 期号: 6, 页码: 2769-2776 作者:  Yan, Weiwei;  Jing, Wang;  An, Ning;  Tian, Yaru;  Guo, Dong 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/11 EGFR-TKIs  leptomeningeal metastasis  non-small-cell lung cancer  survival  WBRT   miR-608 and miR-4513 significantly contribute to the prognosis of lung adenocarcinoma treated with EGFR-TKIs 期刊论文 LABORATORY INVESTIGATION, 2019, 卷号: 99, 期号: 4, 页码: 568-576 作者:  Zhang, Nasha;  Li, Yankang;  Zheng, Yan;  Zhang, Li;  Pan, Yuan 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/11 Dynamic Monitoring of Response Heterogeneity between Primary and Metastases Reveals Resistance Molecular Mechanisms in Advanced Non-Small Cell Lung Cancer with Acquired Resistance to EGFR-TKIs. 会议论文 61st Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), SEP 15-18, 2019 作者:  Dong, X.;  Xing, L.;  Sun, X.;  Wan, H.;  Yu, J. 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/31 Local Consolidative Radiation Prolongs Disease Control of Patients with Oligometastatic NSCLC Harboring EGFR Activating Mutation Treated with First-Line EGFR-TKIs 会议论文 61st Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), SEP 15-18, 2019 作者:  An, N.;  Wang, H.;  Jing, W.;  Zhu, H.;  Yu, J. 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/31 The Functional MDM4 Genetic Polymorphsim as Prognostic Biomarker for Advanced Lung Adenocarcinoma Patients' Survival to EGFR-TKIs Therapy 期刊论文 JOURNAL OF THORACIC ONCOLOGY, 2018, 卷号: 13, 期号: 10, 页码: S593-S593 作者:  Yang, M.;  Zhang, N.;  Xing, H.;  Liu, J. 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/11 functional MDM4 genetic variant  EGFR-TKIs treatment  Prognostic  Biomarker   Leukocyte Telomere Length as a Novel Biomarker in Advanced Lung Adenocarcinoma Patients Treated with Gefitinib 期刊论文 JOURNAL OF THORACIC ONCOLOGY, 2018, 卷号: 13, 期号: 10, 页码: S503-S504 作者:  Yang, M.;  Li, J.;  Zhang, N.;  Liu, J.;  Xing, H. 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/11 biomarker  leukocyte relative telomere length  EGFR-TKIs treatment   First-line therapy for advanced non-small cell lung cancer with activating EGFR mutation: is combined EGFR-TKIs and chemotherapy a better choice? 期刊论文 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 卷号: 81, 期号: 3, 页码: 443-453 作者:  Wang, Shuyun;  Gao, Aiqin;  Liu, Jie;  Sun, Yuping 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/11 Activating EGFR mutation  NSCLC  EGFR-TKIs  Cytotoxic chemotherapy  First-line treatment   miR-608 and miR-4513 significantly contribute to the prognosis of lung adenocarcinoma treated with EGFR-TKIs 期刊论文 Laboratory Investigation, 2018 作者:  Zhang N.;  Li Y.;  Zheng Y.;  Zhang L.;  Pan Y. 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/11 Risk Factors of Brain Metastasis during the Course of EGFR-TKIs Therapy for Patients with EGFR-Mutated Advanced Lung Adenocarcinoma 期刊论文 JOURNAL OF THORACIC ONCOLOGY, 2017, 卷号: 12, 期号: 1, 页码: S1484-S1484 作者:  Zhu, Hui;  Ma, Xiaoyan;  Yu, Jinming 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/11 brain metastases  risk factors  Epidermal growth factor receptor  advanced lung adenocarcinoma